Kaskela Law LLC is investigating Amicus Therapeutics, Inc. (NASDAQ: FOLD) (“Amicus”) on behalf of the company’s shareholders.

Year to date, shares of Amicus’ stock have declined over 32% in value, to trade at a current price of less than $7.00 per share. 

The investigation seeks to determine whether Amicus and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.

Amicus shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750